Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 56, 2021 - Issue 9
Submit an article Journal homepage
1,836
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Bismuth containing quadruple therapy versus tailored therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area

Boram Chaa Department of Internal Medicine, Division of Gastroenterology, Inha University College Medicine, Incheon, Republic of KoreaView further author information
,
Byoung Wook Banga Department of Internal Medicine, Division of Gastroenterology, Inha University College Medicine, Incheon, Republic of KoreaView further author information
,
Jong Beom Shina Department of Internal Medicine, Division of Gastroenterology, Inha University College Medicine, Incheon, Republic of KoreaView further author information
,
Eun Jung Koa Department of Internal Medicine, Division of Gastroenterology, Inha University College Medicine, Incheon, Republic of KoreaView further author information
,
Weonjin Koa Department of Internal Medicine, Division of Gastroenterology, Inha University College Medicine, Incheon, Republic of KoreaView further author information
,
Kye Sook Kwona Department of Internal Medicine, Division of Gastroenterology, Inha University College Medicine, Incheon, Republic of KoreaView further author information
,
Yong Woon Shina Department of Internal Medicine, Division of Gastroenterology, Inha University College Medicine, Incheon, Republic of KoreaView further author information
,
Young Ju Suhb Department of Biostatistics, Inha University College of Medicine, Incheon, Republic of KoreaView further author information
&
Hyungkil Kima Department of Internal Medicine, Division of Gastroenterology, Inha University College Medicine, Incheon, Republic of KoreaCorrespondence[email protected]
View further author information
 show all
Pages 1017-1022 | Received 09 Apr 2021, Accepted 23 Jun 2021, Published online: 08 Aug 2021

References

  • McColl KE. Clinical practice Helicobacter pylori infection. N Engl J Med. 2010;362(17):1597–1604.
  • Malfertheiner P, Megraud F, O'Morain CA, European Helicobacter Study Group, et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence consensus report. Gut. 2012;61(5):646–664.
  • Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59(8):1143–1153.
  • Malfertheiner P, Megraud F, O'Morain CA, European Helicobacter and Microbiota Study Group and Consensus panel, et al. Management of Helicobacter pylori infection – the Maastricht V/Florence consensus report. Gut. 2017;66(1):6–30.
  • Chey WD, Leontiadis GI, Howden CW, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212–239.
  • Kim SG, Jung H, Lee HL, Korean College of Helicobacter and Upper Gastrointestinal Research, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. J Gastroenterol Hepatol. 2014;29(7):1371–1386.
  • Woo H, Park DI, Park H, et al. Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens. Helicobacter. 2009;14(1):22–28.
  • Lee HJ, Kim JI, Cheung DY, et al. Eradication of helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance. J Infect Dis. 2013;208(7):1123–1130.
  • Lee JY, Kim N, Kim MS, et al. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance. Dig Dis Sci. 2014;59(6):1235–1243.
  • Occhialini A, Urdaci M, Doucet-Populaire F, et al. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother. 1997;41(12):2724–2728.
  • Yoon K, Park SW, Lee SW, et al. Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea. J Korean Med Sci. 2014;29(9):1240–1246.
  • Lee JW, Kim N, Kim JM, et al. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter. 2013;18(3):206–214.
  • Lee SW, Kim HJ, Kim JG. Treatment of Helicobacter pylori infection in Korea: a systematic review and meta-analysis. J Korean Med Sci. 2015;30(8):1001–1009.
  • Fallone CA, Chiba N, van Zanten SV, et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016;151(1):51–69. e14.
  • Venerito M, Krieger T, Ecker T, et al. Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection. Digestion. 2013;88(1):33–45.
  • Gweon TG, Kim JS, Kim BW. An economic modeling study of Helicobacter pylori eradication: comparison of dual priming oligonucleotide-based multiplex polymerase chain reaction and empirical treatment. Gut Liver. 2018;12(6):648–654.
  • Smith SM, O'Morain C, McNamara D. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World J Gastroenterol. 2014;20(29):9912–9921.
  • Malfertheiner P, Bazzoli F, Delchier J. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial (vol 377, pg 905, 2011). Lancet. 2011;377:905–913.
  • Francesco VD, Zullo A, Hassan C, et al. Mechanisms of Helicobacter pylori antibiotic resistance: an updated appraisal. World J Gastrointest Pathophysiol. 2011;2(3):35–41.
  • El-Zimaity HM, Al-Assi MT, Genta RM, et al. Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test. Am J Gastroenterol. 1995;90(11):1962–1964.
  • Woo JS, Hala M, Genta RM, et al. The best gastric site for obtaining a positive rapid urease test. Helicobacter. 1996;1(4):256–259.
  • Nishizawa T, Suzuki H. Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing. Front Mol Biosci. 2014;1:19–17.
  • Chen P, Wu M, Chen C, for the Taiwan Gastrointestinal Disease and Helicobacter Consortium, et al. Systematic review with meta‐analysis: the efficacy of levofloxacin triple therapy as the first‐or second‐line treatments of Helicobacter pylori infection. Aliment Pharmacol Ther. 2016;44(5):427–437.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.